TOP 5 INSIGHTS IN CLINICAL SUPPLY CHAIN & LOGISTICS
JUNE EDITION
|
|
|
|
CMC experts play a pivotal role in navigating the complexities of pharmaceutical scale-up. Their technical expertise ensures that the transition from development to commercial production is seamless, compliant, and optimized for efficiency. Here’s how they help manage key challenges:
|
|
|
|
When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
|
|
|
|
Federal workforce reductions pose significant challenges for the life sciences industry, particularly in sectors like biotechnology, medicine, and biology. This article provides a snapshot of what to expect with how the current reduction in force at the FDA impacts your life sciences company and products.
|
|
|
|
Discover how Y-mAbs Therapeutics, Inc.'s novel self-assembly disassembly (SADA) construct uses self-assembling tetramers to deliver isotopes directly to cancer cells for a highly targeted, less toxic treatment
|
|
|
|
Naya Therapeutic's CEO describes the dynamics of producing a complex therapeutic for clinical trials on another continent, and how choice of CDMO plays heavily into that strategy.
|
|
|
|